These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 4295923)

  • 21. [The vasopressin test in the functional assay of the hypothalamo-hypophyseal-adrenal system].
    Kolebinov N
    Vutr Boles; 1974; 13(2):29-34. PubMed ID: 4417376
    [No Abstract]   [Full Text] [Related]  

  • 22. Assessment of hypothalamic-pituitary-adrenal function in the geriatric age group.
    Friedman M; Green MF; Sharland DE
    J Gerontol; 1969 Jul; 24(3):292-7. PubMed ID: 4309803
    [No Abstract]   [Full Text] [Related]  

  • 23. Pituitary adrenal function during corticosteroid withdrawal in rheumatoid arthritis.
    Daly JR; Myles AB; Bacon PA; Beardwell CG; Savage O
    Ann Rheum Dis; 1967 Jan; 26(1):18-25. PubMed ID: 4289304
    [No Abstract]   [Full Text] [Related]  

  • 24. Intermittent steroid therapy. Its effect on hypothalamic-pituitary-adrenal function and the response of plasma growth hormone and insulin to stimulation.
    Martin MM; Gaboardi F; Podolsky S; Raiti S; Calcagno PL
    N Engl J Med; 1968 Aug; 279(6):273-8. PubMed ID: 4298259
    [No Abstract]   [Full Text] [Related]  

  • 25. Where in the world is oral triamcinolone?
    Roger L
    J Rheumatol; 2011 Jul; 38(7):1519; author reply 1519. PubMed ID: 21724726
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of serotonin in hypothalamo pituitary adrenal axis escape from dexamethasone suppression.
    Krishnan KR; Ritchie JC; Manepalli AN; Wilson WH; Saunders WB; Venkataraman SS; Carroll BJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(5):637-42. PubMed ID: 1659724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intranasal atrial natriuretic peptide acts as central nervous inhibitor of the hypothalamo-pituitary-adrenal stress system in humans.
    Perras B; Schultes B; Behn B; Dodt C; Born J; Fehm HL
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4642-8. PubMed ID: 15356075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The hypothalamic-pituitary-adrenal function in children with severe cerebral lesions: an evaluation.
    Faglia G; Manghi E; Ambrosi B; Travaglini P; Norbiato G
    Folia Endocrinol; 1971 Apr; 24(2):94-109. PubMed ID: 4334173
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hypothalamo-hypophyso-adrenal activity under corticotherapy. Comparative study of ACTH, Synacthene, metopirone, lysine-vasopressin and pyrogen tests].
    Bloch-Michel H; Gorins A; Thevenet M
    Ann Endocrinol (Paris); 1969; 30(3):470-9. PubMed ID: 4311601
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
    Straub RH; Pongratz G; Schölmerich J; Kees F; Schaible TF; Antoni C; Kalden JR; Lorenz HM
    Arthritis Rheum; 2003 Jun; 48(6):1504-12. PubMed ID: 12794817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neural control of pituitary adrenal activity in Cyprinus carpio.
    Redgate ES
    Gen Comp Endocrinol; 1974 Jan; 22(1):35-41. PubMed ID: 4360801
    [No Abstract]   [Full Text] [Related]  

  • 32. Diagnosis of Cushing's syndrome. The differentiation between adrenocortical hyperplasia and adrenocrotical adenoma by means of lysine-vasopressin.
    Bethge H; Bayer JM; Winkelmann W
    Acta Endocrinol (Copenh); 1969 Jan; 60(1):47-59. PubMed ID: 4308289
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of corticotropin on the thymus and the hypothalamo-pituitary-adrenal system.
    Guseinov SG; Aliev MG; Kurbanov TG
    Neurosci Behav Physiol; 1983; 13(2):135-8. PubMed ID: 6318152
    [No Abstract]   [Full Text] [Related]  

  • 34. [How to plan glucocorticoid withdrawal: diagnostic and therapeutic strategies].
    Vollenweider P; Waeber G
    Praxis (Bern 1994); 2003 Oct; 92(40):1675-82. PubMed ID: 14579472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Physiological basis of the functional exploration of the hypothalamo-hypophyeo-adrenocortical axis].
    Chalendar D
    Lyon Med; 1972 Jun; 227(12):1197-200. PubMed ID: 4345446
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of the hypophyseal-hypothalamo-adrenal axis in patients undergoing chronic corticotherapy at suppressive doses].
    Gálvez Gudiño VJ
    Rev Alerg Mex; 1993; 40(5):132-4. PubMed ID: 9312341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypothalamus-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with nighttime-release prednisone.
    Alten R; Döring G; Cutolo M; Gromnica-Ihle E; Witte S; Straub R; Buttgereit F
    J Rheumatol; 2010 Oct; 37(10):2025-31. PubMed ID: 20682671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypothalamic-pituitary-adrenal (HPA) axis function in patients receiving long-term intra-articular corticosteroids.
    Reid DM; Patel S; Reid IW; Eastmond CJ; Rennie JA
    Clin Rheumatol; 1983 Jun; 2(2):159-61. PubMed ID: 6678689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of endogenous corticosteroid production by betamethasone.
    Hodges JR; Mitchley S
    J Endocrinol; 1970 Sep; 48(1):13-4. PubMed ID: 4319571
    [No Abstract]   [Full Text] [Related]  

  • 40. Intermittent therapy with corticotrophin.
    Nelson JK; Mackay JS; Sheridan B; Weaver JA
    Lancet; 1966 Jul; 2(7454):78-83. PubMed ID: 4161024
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.